1. Home >
  2. M&A >
  3. Growth Capital >
  4. United States >
  5. Washington >
  6. Sanofi Invests In InduPro

Investment Summary

Sanofi Invests In InduPro

On December 10, 2025, Sanofi invested in life science company InduPro

Investment Highlights
  • This is Sanofi’s 22nd transaction in the Life Science sector.
  • This is Sanofi’s 19th transaction in the United States.
  • This is Sanofi’s 1st transaction in Washington.

Investment Summary
Date 2025-12-10
Target InduPro
Sector Life Science
Investor(s) Sanofi
Deal Type Growth Capital

Target

InduPro

Seattle, Washington, United States
InduPro is a biotechnology company defining and harnessing inherent and induced proximity biology to unlock next-generation therapeutics in cancer and autoimmune diseases. The Company develops therapeutics against novel, tumor-selective targets and co-target pairs using bispecific antibodies including antibody drug conjugates (ADCs) and T cell engagers (TCEs), fueling a robust pipeline of first- and best-in-class programs. InduPro is based in Seattle, Washington.

Search 214,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Sanofi

Paris, France
Category Company
Founded 1994
Sector Life Science
Employees82,878
Revenue 44.3B EUR (2024)
DESCRIPTION

Sanofi is a French multinational pharmaceutical company. Sanofi was founded in 1994 and is based in Paris, France.

DEAL STATS #
Overall 31 of 31
Sector: Life Science M&A 22 of 22
Type: Growth Capital M&A Deals 1 of 1
State: Washington M&A 1 of 1
Country: United States M&A 19 of 19
Year: 2025 M&A 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-09-02 Sanofi - Sterile Fill-Finish & Packaging Site

Ridgefield, New Jersey, United States

Sanofi - Sterile Fill-Finish & Packaging Site is a sterile fill-finish manufacturing site.

Sell -
Mergr

Solution for

Product

Company

Legal